Land: Malaysia
Sprache: Englisch
Quelle: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
GABAPENTIN
DYNAPHARM (M) SDN BHD
GABAPENTIN
500capsule Capsules; 100capsule Capsules
DYNAPHARM (M) SDN BHD
Consumer Medication Information Leaflet (RiMUP) DYNA GABAPENTIN CAPSULE 300MG Gabapentin (300mg) 1 What is in this leaflet 1. What GABAPENTIN is used for 2. How GABAPENTIN works 3. Before you use GABAPENTIN 4. How to use GABAPENTIN 5. While you are using it 6. Side effects 7. Storage and Disposal of GABAPENTIN 8. Product Description 9. Manufacturer and Product Registration Holder 10. Date of revision 11. Serial number 1. What GABAPENTIN is used for Epilepsy: Gabapentin is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children age 3 years and above. Safety and effectiveness for adjunctive therapy in pediatric patients below the age of 3 years have not been established. Neuropathic pain: Gabapentin is indicated for the treatment of neuropathic pain which includes diabetic neuropathy, post- herpetic neuralgia and trigeminal neuralgia in adults age 18 years and above. Safety and effectiveness in patients below the age of 18 years have not been established. 2. How GABAPENTIN works Gabapentin belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long lasting pain caused by damage to the nerves). 3. Before you use GABAPENTIN - When you must not use it DO NOT TAKE this medication if you are allergic (hypersensitive) to gabapentin or any of the other ingredients. Take special care with Gabapentin - If you suffer from kidney problems your doctor may prescribe a different dosing schedule - If you are on haemodialysis (to remove waste products because of kidney failure), tell your doctor - If you develop muscle pain and/or weakness - If you develop signs such as persistent stomach pain, feeling sick and being sick contact your doctor immediately as these may be symptoms of acute pancreatitis (an inflamed pancreas). - A small number of people being treated with anti-epileptics such as gabapentin have had thoughts of harming or killing themselves. If at any time you have these thoughts, immediately contact your doct Lesen Sie das vollständige Dokument
DYNA GABAPENTIN CAPSULE 300MG MAL17055007AZ Each capsule contains 300 mg of the active ingredient gabapentin. PRODUCT DESCRIPTION Yellow cap & yellow body hard gelatin capsule of size ‘1’ containing white to off-white powder PHARMACODYNAMICS Gabapentin is structurally related to the neurotransmitter GABA; however, gabapentin and its metabolites do not bind to GABA (A) or GABA (B) receptors or influence the degradation or uptake of GABA. The analgesic action of gabapentin has been demonstrated in animal models of analgesia where gabapentin prevented allodynia and hyperalgesia. Pain related responses in neuropathic pain models and in peripheral inflammation models were prevented or decreased by gabapentin. Immediate pain-related behaviors were not altered. The mechanism by which gabapentin exerts its analgesic effects is unknown. It has been suggested the mechanism of action may be by gabapentin preventing thrombospondin from binding to alpha-2 delta-1 (a receptor involved in excitatory synapse formation). The anticonvulsant action of gabapentin has been demonstrated in animal test systems; however, the mechanism by which gabapentin prevents seizure activity is unknown. PHARMACOKINETICS Absorption Gabapentin bioavailability is not dose-proportional. That is, as the dose is increased, bioavailability decreases. Gabapentin is absorbed from the gastrointestinal tract by means of a saturable mechanism. After multiple dosing peak plasma concentrations usually occur within 2 to 3 hours of a dose and a steady state within 1 to 2 days. Absolute bioavailability of gabapentin capsules is approximately 60%. Distribution Gabapentin is distributed into breast milk. It is widely distributed throughout the body but binding to plasma proteins is minimal. It has a volume of distribution equal to 57.7 liters. Metabolism Gabapentin is excreted unchanged in the urine, and is not appreciably metabolized. Excretion The elimination half-life of gabapentin is independent of dose and averages 5 to 7 hours. The renal clearance of gabape Lesen Sie das vollständige Dokument